Dea

By

25 Jul 2026

DEA's Own Witness Undercuts Its Case for Excluding a Drug Developer

A federal drug developer that DEA barred from testifying at its own rescheduling hearing says the agency's reasoning collapsed weeks later, when one of its scientific witnesses raised the exact

• DEA

By

30 May 2026

Jushi Applies for DEA Registration as Federal Medical Cannabis Framework Takes Shape

Jushi Holdings Inc. has submitted applications to the U.S. Drug Enforcement Administration seeking federal registration for certain state-licensed medical marijuana operations - a direct response to

• Jushi Holdings Inc.

By

05 May 2026

DEA Opens Cannabis Registration Portal, but Many Operators Are Weighing the Risks

The federal government has cracked open a door it kept sealed for decades - and the cannabis industry isn't sure whether to walk through it. On April 29, the Drug Enforcement Administration's

• DEA